Metraipolis › archive › dc_f082d4844779
Developmental Toxicity Assessment of Piperonyl Butoxide Exposure Targeting Sonic Hedgehog Signaling and Forebrain and Face Morphogenesis in the Mouse: An in… — Europe PMC PMID:31642701
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/31642701
- DOI
- 10.1289/ehp5260
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-10T06:42:23.262Z
- SHA-256 of the archived text
340614591f79e74a8ff3c76f6dbae5c414ddbe08593ce5b10795f2e6be402498- Stable URL of this page
https://metraipolis.com/documento/dc_f082d4844779
How to cite
Developmental Toxicity Assessment of Piperonyl Butoxide Exposure Targeting Sonic Hedgehog Signaling and Forebrain and Face Morphogenesis in the Mouse: An in… — Europe PMC PMID:31642701 — Europe PMC (en), https://europepmc.org/article/MED/31642701 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_f082d4844779 (Metraipolis archive dc_f082d4844779, sha256 340614591f79e74a8ff3c76f6dbae5c414ddbe08593ce5b10795f2e6be402498)
BibTeX
@misc{dcf082d4844779,
title = {Developmental Toxicity Assessment of Piperonyl Butoxide Exposure Targeting Sonic Hedgehog Signaling and Forebrain and Face Morphogenesis in the Mouse: An in… — Europe PMC PMID:31642701},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/31642701},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_f082d4844779; sha256 340614591f79e74a8ff3c76f6dbae5c414ddbe08593ce5b10795f2e6be402498},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31642701. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Piperonyl butoxide (PBO) is a pesticide synergist used in residential, commercial, and agricultural settings. PBO was recently found to inhibit Sonic hedgehog (Shh) signaling, a key developmental regulatory pathway. Disruption of Shh signaling is linked to birth defects, including holoprosencephaly (HPE), a malformation of the forebrain and face thought to result from complex gene-environment interactions. Objectives: The impact of PBO on Shh signaling in vitro and forebrain and face development in vivo was examined. Methods: The influence of PBO on Shh pathway transduction was assayed in mouse and human cell lines. To examine its teratogenic potential, a single dose of PBO (22-1,800mg/kg) was administered by oral gavage to C57BL/6J mice at gestational day 7.75, targeting the critical period for HPE. Gene-environment interactions were investigated using Shh+/- mice, which model human HPE-associated genetic mutations. Results: PBO attenuated Shh signaling in vitro through a mechanism similar to that of the known teratogen cyclopamine. In utero PBO exposure caused characteristic HPE facial dysmorphology including dose-dependent midface hypoplasia and hypotelorism, with a lowest observable effect level of 67mg/kg. Median forebrain deficiency characteristic of HPE was observed in severely affected animals, whereas all effective doses disrupted development of Shh-dependent transient forebrain structures that generate cortical interneurons. Normally silent heterozygous Shh null mutations exacerbated PBO teratogenicity at all doses tested, including 33mg/kg. Discussion: These findings demonstrate that prenatal PBO exposure can cause overt forebrain and face malformations or neurodevelopmental disruptions with subtle or no craniofacial dysmorphology in mice. By targeting Shh signaling as a sensitive mechanism of action and examining gene-environment interactions, this study defined a lowest observable effect level for PBO developmental toxicity in mice more than 30-fold lower than previously recognized. Human exposure to PBO and its potential contribution to etiologically complex birth defects should be rigorously examined. https://doi.org/10.1289/EHP5260. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Environmental health perspectives, 2019 (prima pubblicazione 2019-10-23). Identificativi: PMID 31642701 · PMCID PMC6867268 · DOI 10.1289/ehp5260. Pagina: https://europepmc.org/article/MED/31642701 — https://doi.org/10.1289/ehp5260. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-10T06:39:05.483Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.